Tau and alpha-synuclein pathology in amygdala of Parkinsonism-dementia complex patients of Guam.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  American Journal of Pathology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 12000724PMCID PMC1850878
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Progressive supranuclear palsy with Lewy bodies

  2004cited by this paper
• Monoclonal antibodies with selective specificity for Alzheimer Tau are directed against phosphatase-sensitive epitopes

  2004cited by this paper
• Co-occurrence of Parkinson's disease with progressive supranuclear palsy

  2002cited by this paper
• beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease.

  2001cited by this paper
• TAU as a susceptibility gene for amyotropic lateral sclerosis-parkinsonism dementia complex of Guam.

  2001cited by this paper
• Neuropathology of synuclein aggregates

  2000cited by this paper
• Juvenile-onset generalized neuroaxonal dystrophy (Hallervorden-Spatz disease) with diffuse neurofibrillary and Lewy body pathology

  2000cited by this paper
• A panel of epitope‐specific antibodies detects protein domains distributed throughout human α‐synuclein in lewy bodies of Parkinson's disease

  2000cited by this paper
• Occurrence of human alpha-synuclein immunoreactive neurons with neurofibrillary tangle formation in the limbic areas of patients with Alzheimer's disease.

  2000cited by this paper
• Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions.

  2000cited by this paper
• Lewy Bodies in Alzheimer's Disease: A Neuropathological Review of 145 Cases Using α‐Synuclein Immunohistochemistry

  2000cited by this paper
• Tau protein isoforms, phosphorylation and role in neurodegenerative disorders.

  2000cited by this paper
• α‐Synuclein Inclusions in Amygdala in the Brains of Patients with the Parkinsonism‐Dementia Complex of Guam

  2000cited by this paper
• Widespread expression of alpha-synuclein and tau immunoreactivity in Hallervorden-Spatz syndrome with protracted clinical course.

  2000cited by this paper
• Tau epitopes in spinal cord neurofibrillary lesions in Chamorros of Guam

  2000cited by this paper
• New insights into genetic and molecular mechanisms of brain degeneration in tauopathies.

  2000cited by this paper
• Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform.

  1999cited by this paper
• Frequent coexistence of Lewy bodies and neurofibrillary tangles in the same neurons of patients with diffuse Lewy body disease.

  1999cited by this paper
• Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.

  1999cited by this paper
• α-Synuclein Binds to Tau and Stimulates the Protein Kinase A-catalyzed Tau Phosphorylation of Serine Residues 262 and 356*

  1999cited by this paper
• Neuropathology of parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam: an update

  1999cited by this paper
• Parkinsonism-dementia complex on Guam — Overview of clinical aspects

  1999cited by this paper
• Purification of paired helical filament tau and normal tau from human brain tissue.

  1999cited by this paper
• Antibodies to α‐synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease

  1999cited by this paper
• Amyloid plaques in Guam amyotrophic lateral sclerosis/ parkinsonism-dementia complex contain species of Aβ similar to those found in the amyloid plaques of Alzheimer’s disease and pathological aging

  1998cited by this paper
• Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes.

  1998cited by this paper
• Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17.

  1998cited by this paper
• Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.

  1998cited by this paper
• Corticobasal degeneration

  1997cited by this paper
• Distinct Pathological Features of the Gallyas‐ and Tau‐positive Glia in the Parkinsonism‐Dementia Complex and Amyotrophic Lateral Sclerosis of Guam

  1997cited by this paper
• Identification of phosphorylation sites in PHF-TAU from patients with Guam amyotrophic lateral sclerosis/parkinsonism-dementia complex.

  1996cited by this paper
• Convergence of Lewy bodies and neurofibrillary tangles in amygdala neurons of Alzheimer’s disease and Lewy body disorders

  1996cited by this paper
• Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205.

  1995cited by this paper
• Neurofibrillary degeneration in amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam. Immunochemical characterization of tau proteins.

  1995cited by this paper
• Detection of Phosphorylated Ser262 in Fetal Tau, Adult Tau, and Paired Helical Filament Tau (*)

  1995cited by this paper
• Cortical Lewy bodies in Alzheimer's disease.

  1995cited by this paper
• Progressive supranuclear palsy

  1994cited by this paper
• Amyotrophic lateral sclerosis and parkinsonism-dementia from Guam: differences in neurofibrillary tangle distribution and density in the hippocampal formation and neocortex.

  1994cited by this paper
• An autopsy case of late infantile and juvenile neuroaxonal dystrophy with diffuse Lewy bodies and neurofibrillary tangles.

  1992cited by this paper
• Neurofibrillary tangle distribution in the cerebral cortex of parkinsonism-dementia cases from Guam: differences with Alzheimer's disease.

  1991cited by this paper
• Beta (A4)-amyloid protein and parkinsonian dementia complex of Guam.

  1991cited by this paper
• A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis.

  1990cited by this paper
• Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease.

  1989cited by this paper
• Cloning and sequencing of the cDNA encoding an isoform of microtubule‐associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain.

  1989cited by this paper
• Epitopes that span the tau molecule are shared with paired helical filaments.

  1988cited by this paper
• Amyotrophic lateral sclerosis and Parkinson's disease complex on Guam linked to an environmental neurotoxin.

  1988cited by this paper
• Phosphate dependent and independent neurofilament epitopes in the axonal swellings of patients with motor neuron disease and controls.

  1987cited by this paper
• Neurofibrillary change on Guam.

  1981cited by this paper
• The fine structure of some intraganglionic alterations. Neurofibrillary tangles, granulovacuolar bodies and "rod-like" structures as seen in Guam amyotrophic lateral sclerosis and parkinsonism-dementia complex.

  1968cited by this paper
• Amyotrophic lateral sclerosis and Parkinsonism-dementia complex on Guam. Further pathologic studies.

  1966cited by this paper

• Guam amyotrophic lateral sclerosis/parkinsonism-dementia complex (ALS/PDC) features CTE-like tau seeds in brain and spinal cord

  2025cites this paper
• Genetic factors and comorbid pathologies interact to drive regional mitophagy alterations in Lewy body dementia

  2025cites this paper
• The genetics of neurodegenerative diseases is the genetics of age-related damage clearance failure

  2025cites this paper
• α-synuclein and tau: interactions, cross-seeding, and the redefinition of synucleinopathies as complex proteinopathies

  2025cites this paper
• Development of Patient-Derived Neuroprogenitor Cells (hNPCs), Neurons and Astrocytes to Explore the Etiology of Guam Parkinsonism-Dementia Complex (PDC)

  2025cites this paper
• The Vital Role of Melatonin and Its Metabolites in the Neuroprotection and Retardation of Brain Aging

  2024cites this paper
• In vivo detection of Alzheimer's and Lewy body disease concurrence: Clinical implications and future perspectives

  2024cites this paper
• Secondary Protein Aggregates in Neurodegenerative Diseases: Almost the Rule Rather than the Exception.

  2023cites this paper
• Endemic parkinsonism: clusters, biology and clinical features

  2023cites this paper
• Role of Animal Models in Parkinson's Disease (PD): What role they play in preclinical translational research.

  2023cites this paper
• Guam ALS-PDC is a distinct double-prion disorder featuring both tau and Aβ prions

  2023cites this paper
• Investigating the Pathogenic Interplay of Alpha-Synuclein, Tau, and Amyloid Beta in Lewy Body Dementia: Insights from Viral-Mediated Overexpression in Transgenic Mouse Models

  2023cites this paper
• Functional Cooperation of α-Synuclein and Tau Is Essential for Proper Corticogenesis

  2022cites this paper
• MGMT, a risk factor for both genetic and environmental forms of dementia

  2022cites this paper
• Tau and GSK-3β are Critical Contributors to α-Synuclein-Mediated Post-Stroke Brain Damage

  2022cites this paper
• The Genetics of Amygdaloid Disorders

  2021cites this paper
• Synuclein in neurodegeneration.

  2021cites this paper
• Tau induces formation of α-synuclein filaments with distinct molecular conformations.

  2021cites this paper
• Distinct cryo-EM Structure of α-synuclein Filaments derived by Tau

  2021cites this paper
• Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.

  2021cites this paper
• The interaction of α-synuclein and Tau: A molecular conspiracy in neurodegeneration?

  2020cites this paper
• Cell-free amplification of prions: Where do we stand?

  2020cites this paper
• Neuronal clusterin expression is associated with cognitive protection in amyotrophic lateral sclerosis

  2019cites this paper
• Tau Interacts with the C-Terminal Region of α-Synuclein, Promoting Formation of Toxic Aggregates with Distinct Molecular Conformations.

  2019cites this paper
• Diverse Misfolded Conformational Strains and Cross-seeding of Misfolded Proteins Implicated in Neurodegenerative Diseases

  2019cites this paper
• Reply to ‘TMEM230 variants in Parkinson’s disease’ and ‘Doubts about TMEM230 as a gene for parkinsonism’

  2019cites this paper
• Possible Role of Amyloid Cross-Seeding in Evolvability and Neurodegenerative Disease

  2019cites this paper
• α-Synuclein Oligomers Induce a Unique Toxic Tau Strain

  2018cites this paper
• Dysfunction of Protein Quality Control in Parkinsonism–Dementia Complex of Guam

  2018cites this paper
• Formation of Heterotypic Amyloids: α‐Synuclein in Co‐Aggregation

  2018cites this paper
• Cerebrovascular inflammation is associated with tau pathology in Guam parkinsonism dementia

  2018cites this paper
• The Amygdala as a Locus of Pathologic Misfolding in Neurodegenerative Diseases

  2018cites this paper
• Accumulation of multiple neurodegenerative disease-related proteins in familial frontotemporal lobar degeneration associated with granulin mutation

  2017cites this paper
• Conformation as the Therapeutic Target for Neurodegenerative Diseases.

  2017cites this paper
• Potential biomarkers and novel pharmacological targets in protein aggregation‐related neurodegenerative diseases

  2017cites this paper
• Cannabinoid Therapeutics in Parkinson’s Disease: Promise and Paradox

  2017cites this paper
• MultiTEP platform-based DNA vaccines for alpha-synucleinopathies: preclinical evaluation of immunogenicity and therapeutic potency.

  2017cites this paper
• Protein arginylation targets alpha synuclein, facilitates normal brain health, and prevents neurodegeneration

  2017cites this paper
• Misfolded proteins affect synaptic plasticity and network activity

  2017cites this paper
• Non-Amyloid-β Component of Human α-Synuclein Oligomers Induces Formation of New Aβ Oligomers: Insight into the Mechanisms That Link Parkinson's and Alzheimer's Diseases.

  2016cites this paper
• Identification of genetic modifiers in LRRK2 parkinsonism

  2016cites this paper
• Parkinson's disease as a member of Prion-like disorders.

  2015cites this paper
• The Synaptic Function of α-Synuclein

  2015cites this paper
• Abnormal Paraplegin Expression in Swollen Neurites, τ- and α-Synuclein Pathology in a Case of Hereditary Spastic Paraplegia SPG7 with an Ala510Val Mutation

  2015cites this paper
• Concomitant accumulation of α-synuclein and TDP-43 in a patient with corticobasal degeneration

  2014cites this paper
• New α- and γ-synuclein immunopathological lesions in human brain

  2014cites this paper
• Alpha-synuclein and tau: teammates in neurodegeneration?

  2014cites this paper
• Atypical Alzheimer's disease in an elderly United States resident with amyotrophic lateral sclerosis and pathological tau in spinal motor neurons

  2014cites this paper
• Einzelmolekülbasierte Analyse des Aggregationsverhaltens von Tau-Protein und sein Verhalten in der Koaggregation mit Alpha-Synuklein

  2014cites this paper
• Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series

  2013cites this paper
• Mechanisms underlying beta-N-methylamino-L-alanine neurotoxicity in different model systems

  2013cites this paper
• Confluence of α-synuclein, tau, and β-amyloid pathologies in dementia with Lewy bodies.

  2013cites this paper
• &agr;-Synuclein Pathology in the Amyotrophic Lateral Sclerosis/Parkinsonism Dementia Complex in the Kii Peninsula, Japan

  2012cites this paper
• Neuropathology underlying clinical variability in patients with synucleinopathies

  2011cites this paper
• The ALS/PDC syndrome of Guam: potential biomarkers for an enigmatic disorder.

  2011cites this paper
• Guam dementia syndrome revisited in 2011.

  2011cites this paper
• Tauopathic Changes in the Striatum of A53T α-Synuclein Mutant Mouse Model of Parkinson's Disease

  2011cites this paper
• Spinal cord and parkinsonism: neuromorphological evidences in humans and experimental studies.

  2011cites this paper
• Tau Enhances α-Synuclein Aggregation and Toxicity in Cellular Models of Synucleinopathy

  2011cites this paper
• Region-specific tauopathy and synucleinopathy in brain of the alpha-synuclein overexpressing mouse model of Parkinson's disease

  2011cites this paper
• A mutation affecting the sodium/proton exchanger, SLC9A6, causes mental retardation with tau deposition.

  2010influential citation
• Isolation of short peptide fragments from alpha-synuclein fibril core identifies a residue important for fibril nucleation: a possible implication for diagnostic applications.

  2010cites this paper
• Coexistence of parkinsonism, dementia and upper motor neuron syndrome in four Czech patients.

  2010cites this paper
• Neuropathology of non-Alzheimer degenerative disorders.

  2010cites this paper
• Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia.

  2010influential citation
• [The complexes of degenerative dementias: an evolution from disease to spectrum].

  2009cites this paper
• A phenotypic and neuropathological assessment of the impact of fetal and secondary adult re-exposures to steryl glucosides in mice

  2009cites this paper
• The LEARn model: an epigenetic explanation for idiopathic neurobiological diseases

  2009cites this paper
• Early-Onset Familial Lewy Body Dementia With Extensive Tauopathy: A Clinical, Genetic, and Neuropathological Study

  2009cites this paper
• Absence of α-synuclein pathology in postencephalitic parkinsonism

  2009cites this paper
• Neuropathology of Lewy body disorders.

  2009cites this paper
• Protein aggregation as a paradigm of aging.

  2009cites this paper
• Enduring involvement of tau, β-amyloid, α-synuclein, ubiquitin and TDP-43 pathology in the amyotrophic lateral sclerosis/parkinsonism–dementia complex of Guam (ALS/PDC)

  2008cites this paper
• Proteomics of Human Neurodegenerative Diseases

  2008cites this paper
• The syndromes of frontotemporal dysfunction in amyotrophic lateral sclerosis

  2008cites this paper
• The alpha-synuclein burden hypothesis of Parkinson disease and its relationship to Alzheimer disease.

  2008cites this paper
• Proteomic identification of proteins in the human brain: Towards a more comprehensive understanding of neurodegenerative disease

  2008cites this paper
• Sporadický "guamský parkinsonský komplex" nebo koincidence více neurodegenerativních onemocnění?

  2008cites this paper
• CYANOBACTERIAL TOXINS IN NEURODEGENERATION

  2008cites this paper
• Pathological TDP-43 in parkinsonism–dementia complex and amyotrophic lateral sclerosis of Guam

  2007cites this paper
• Chaperones and proteases

  2007cites this paper
• Analysis of the Adrenal Gland Is Useful for Evaluating Pathology of the Peripheral Autonomic Nervous System in Lewy Body Disease

  2007cites this paper
• Symptomatic REM sleep behaviour disorder

  2007cites this paper
• Interactions of amyloidogenic proteins

  2007cites this paper
• Is there a role for naturally occurring cyanobacterial toxins in neurodegeneration? The beta-N-methylamino-L-alanine (BMAA) paradigm.

  2007cites this paper
• Quantitative proteomics identifies surfactant-resistant alpha-synuclein in cerebral cortex of Parkinsonism-dementia complex of Guam but not Alzheimer's disease or progressive supranuclear palsy.

  2007cites this paper
• Tales of Pacific tangles

  2007cites this paper
• Characterization of tau pathologies in gray and white matter of Guam parkinsonism-dementia complex

  2006cites this paper
• Lewy bodies.

  2006cites this paper
• The neurotoxin, MPP+, induces hyperphosphorylation ofTau, in the presence of α-Synuclein, in SH-SY5Y neuroblastoma cells

  2006cites this paper
• Proteomic analysis of the genotoxicant methylazoxymethanol (MAM)-induced changes in the developing cerebellum.

  2006cites this paper
• Interface between tauopathies and synucleinopathies: A tale of two proteins

  2006cites this paper
• Drug discovery: selecting the optimal approach.

  2006cites this paper
• Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies.

  2006cites this paper
• Novel Ubiquitin Neuropathology in Frontotemporal Dementia With Valosin-Containing Protein Gene Mutations

  2006cites this paper
• The distribution pattern of pathology and cholinergic deficits in amygdaloid complex in Alzheimer's disease and dementia with Lewy bodies

  2006cites this paper
• Multiple pathologies in a patient with a progressive neurodegenerative syndrome

  2005cites this paper
• Staging of Sporadic Parkinson Disease-Related α-Synuclein Pathology: Inter- and Intra-Rater Reliability

  2005cites this paper
• Tau phosphorylation increases in symptomatic mice overexpressing A30P alpha-synuclein.

  2005cites this paper
• Return of the cycad hypothesis – does the amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health?

  2005cites this paper